Apr 30, 2026 | Feature, National
CNBC’s Brandon Gomez reports on the Trump administration’s move to reclassify cannabis as a Schedule III drug. The change doesn’t legalize the drug at the federal level but it could significantly expand scientific research in the drug’s medical uses. More From...
Apr 27, 2026 | Feature, National
The cannabis industry finally got the jolt it’s been waiting for. With the federal government moving cannabis from Schedule I to Schedule III, the conversation has shifted from if reform will happen to what happens next. To unpack the implications, I sat down with...